Experience

35Pharma Closes $53 Million Series C Financing

November 26, 2024

Cooley advised 35Pharma, a clinical-stage biopharmaceutical company developing transforming growth factor-beta superfamily therapeutics, on IP due diligence connected to its strategic $53 million Series C financing. 35Pharma plans to use the proceeds to advance its pipeline of activin and growth differentiation factor inhibitors, HS135 for pulmonary hypertension and HS235 for cardiometabolic disease and obesity.

Related contacts

Dr. Michael Tuscan
Partner, Washington, DC
Dr. Jordan Phelan
Associate, Washington, DC

Related Practices & Industries

HealthCare Royalty and Blue Owl Announce $250 Million Debt Financing With TG Therapeutics

August 6, 2024

Cooley advised Blue Owl Capital (NYSE: OWL), a top asset manager that is redefining alternatives, and HealthCare Royalty (HCRx), a top royalty acquisition company focused on commercial or near-commercial biopharmaceutical products, on a $250 million term loan facility with TG Therapeutics (NASDAQ: TGTX), a fully integrated, commercial-stage biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases.

Read more

Related contacts

Michael Tollini
Partner, Washington, DC
Mischi a Marca
Partner, San Francisco
Addison Pierce
Partner, Chicago
Geoffrey Spolyar
Partner, Boston
Dr. Jon Cousin
Partner, Washington, DC
Xander Lee
Partner, Santa Monica
Michael Egan
Partner, Washington, DC
Steve Flores
Partner, Chicago
Phil Mitchell
Partner, New York
Jason Savich
Partner, San Francisco
Daniel Shamah
Partner, New York
Shimeng Cheng
Special Counsel, San Francisco
Susan Piascik Christoff
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Amanda Pacheco
Associate, Palo Alto
Dr. Jordan Phelan
Associate, Washington, DC
Matt Kong
Associate, San Francisco
Allison Kutner
Associate, New York
Sarah Miller
Associate, New York
Stevie Yu
Associate, New York

Related Practices & Industries

Admissions and credentials

US Patent and Trademark Office

District of Columbia

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.